Literature DB >> 12694549

Quick detection of Leishmania in peripheral blood by flow cytometry. Is prestorage leucodepletion necessary for leishmaniasis prevention in endemic areas?

D S Kyriakou1, M G Alexandrakis, F H Passam, T V Kourelis, P Foundouli, E Matalliotakis, A N Maniatis.   

Abstract

Leishmaniasis is a serious health problem in various endemic areas. There are reports that the parasite can be transmitted via blood transfusions. We studied the clinical utility of flow cytometry for the screening of blood donors in an endemic area in Greece. Samples from 2000 blood donors from the area of Lasithi, Crete, Greece were examined by flow cytometry after labelling with a polyclonal anti-leishmania antibody conjugated with fluorescein-isothiocyanate derived from infected canines in the area. The same blood samples were simultaneously examined for serum anti-leishmania antibodies, May-Grünwald staining of peripheral blood smears and polymerase chain reaction (PCR) in buffy coat to the minicircle of kinetoplastic DNA. Direct sequencing of the PCR-amplified area helped discriminate leishmania species. Flow cytometry detected 33 cases with parasites in the peripheral blood leucocytes (1.65%), which were confirmed by PCR. One PCR-positive case was negative by flow cytometry. After prestorage leucodepletion, no sample was positive by PCR. Anti-leishmania antibodies were positive in 304 (15%) cases. Flow cytometry was found to be a sensitive and rapid method of detecting leishmania in peripheral blood samples. Leucodepletion effectively reduces the detection of the parasite, thus minimizing the potential risk of leishmania transmission through blood transfusions in endemic areas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12694549     DOI: 10.1046/j.1365-3148.2003.00420.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  11 in total

1.  The utility of pathogen inactivation technology: a real-life example of Leishmania infantum inactivation in platelets from a donor with an asymptomatic infection.

Authors:  Teresa Jimenez-Marco; Cristina Riera; Roser Fisa; Enrique Girona-Llobera; Matilde Sedeño; Raymond P Goodrich; Alba Pujol; Carmen Guillen; Josep Muncunill
Journal:  Blood Transfus       Date:  2012-07-04       Impact factor: 3.443

2.  Re-emergence of visceral and cutaneous leishmaniasis in the Greek Island of Crete.

Authors:  Vasiliki Christodoulou; Maria Antoniou; Pantelis Ntais; Ippokratis Messaritakis; Vladimir Ivovic; Jean-Pierre Dedet; Francine Pratlong; Vít Dvorak; Yiannis Tselentis
Journal:  Vector Borne Zoonotic Dis       Date:  2012-01-04       Impact factor: 2.133

3.  Strategies for reducing the risk of transfusion-transmitted leishmaniasis in an area endemic for Leishmania infantum: a patient- and donor-targeted approach.

Authors:  Teresa Jimenez-Marco; Cristina Riera; Enrique Girona-Llobera; Carmen Guillen; Laura Iniesta; Magdalena Alcover; Diana Berenguer; Alba Pujol; Miriam Tomás-Pérez; Beatriz Cancino-Faure; Teresa Serra; Martín Mascaró; Joan Gascó; Roser Fisa
Journal:  Blood Transfus       Date:  2017-03-15       Impact factor: 3.443

4.  Serological Assessment for Leishmania donovani Infection in Blood Donors of Sunsari District, Dharan, Nepal.

Authors:  Suraj Timilsina; Narayan Raj Bhattarai; Basudha Khanal; Suman Rijal
Journal:  Indian J Hematol Blood Transfus       Date:  2015-01-18       Impact factor: 0.900

5.  Leishmaniases in Northern Greece: seroprevalence of the infection and incidence of the disease during the period 2001-2006.

Authors:  E Diza; A Kansouzidou; S Gerou; E Vezyri; S Metallidis; A Antoniadis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-30       Impact factor: 3.267

6.  Validation of rK39 immunochromatographic test and direct agglutination test for the diagnosis of Mediterranean visceral leishmaniasis in Spain.

Authors:  Mathieu Bangert; María D Flores-Chávez; Ivonne P Llanes-Acevedo; Carolina Arcones; Carmen Chicharro; Emilia García; Sheila Ortega; Javier Nieto; Israel Cruz
Journal:  PLoS Negl Trop Dis       Date:  2018-03-01

7.  Prevalence of asymptomatic Leishmania infection and associated risk factors, after an outbreak in the south-western Madrid region, Spain, 2015.

Authors:  Ana Victoria Ibarra-Meneses; Eugenia Carrillo; Javier Nieto; Carmen Sánchez; Sheila Ortega; Alicia Estirado; Pello Latasa Zamalloa; Juan Carlos Sanz; Luis García-Comas; María Ordobás; Javier Moreno
Journal:  Euro Surveill       Date:  2019-05

Review 8.  Spread of vector-borne diseases and neglect of Leishmaniasis, Europe.

Authors:  Jean-Claude Dujardin; Lenea Campino; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Ketty Soteriadou; Apostolos Mazeris; Yusuf Ozbel; Marleen Boelaert
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

9.  Leishmania infection in blood donors: A new challenge in leishmaniasis transmission?

Authors:  Adriana de Oliveira França; Mauricio Antonio Pompilio; Elenir Rose Jardim Cury Pontes; Márcia Pereira de Oliveira; Luiza Oliveira Ramos Pereira; Rosimar Baptista Lima; Hiro Goto; Maria Carmen Arroyo Sanchez; Mahyumi Fujimori; Manoel Sebastião da Costa Lima-Júnior; Maria de Fatima Cepa Matos; Maria Elizabeth Moraes Cavalheiros Dorval
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

10.  Parasitemia and its daily variation in canine leishmaniasis.

Authors:  Simona Di Pietro; Chiara Crinò; Annastella Falcone; Rosalia Crupi; Francesco Francaviglia; Fabrizio Vitale; Elisabetta Giudice
Journal:  Parasitol Res       Date:  2020-08-15       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.